Potentiation of the effects of enoximone by a dobutamine infusion

Abstract

Enoximone is a new inotropic agent, which acts by the inhibition of the type III phosphodiesterase (PDE) enzyme. The present report describes a 81-year-old female patient with severe heart failure following aortic valve replacement. Her cardiac activity was paced. The addition of enoximone (two doses of 0.5 mg/kg) to an intravenous infusion of dobutamine (8… (More)
DOI: 10.1007/BF00273566

1 Figure or Table

Topics

  • Presentations referencing similar topics